This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita HealthCare Partners Inc (DVA)

NYSE: Health Care

$73.03 -1.30 | -1.70%
11/30/15 - 3:59:58 PM ET (BATS BZX Real-time Price)
  • Prev Close: 74.32
  • Day's Open: 74.69
  • Volume: 1.93M
  • Avg Vol: 1.14M
  • Shares Outstanding: 211.00M
  • Mkt Cap: 15.56B
  • Div: --
  • Div Yield: --
  • P/E: 33.22
  • EPS: 3.41
DVA Day's Range
DVA 52 Week Range
DVA Business Summary
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners.View DVA key stats
DaVita HealthCare Partners Inc - DVA - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates DaVita HealthCare Partners Inc as a Buy with a ratings score of B.
Report Snippet: We rate DAVITA HEALTHCARE PARTNERS (DVA) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income and revenue growth. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.
Rating: 3.67 out of 5, 'B' Buy.
You can view the full analysis from the report here:
DVA Rating Report
DVA Earnings Transcripts
  • DaVita Healthcare Partners (DVA) Earnings Report: Q3 2015 Conference Call Transcript
    TheStreet | 11/04/15 - 08:57 AM EST
  • DaVita Healthcare (DVA) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 08/05/15 - 08:48 AM EDT
  • DaVita HealthCare Partners (DVA) Earnings Report: Q1 2015 Conference Call Transcript
    TheStreet | 05/06/15 - 10:14 AM EDT
  • DaVita HealthCare Partners (DVA) Earnings Report: Q4 2014 Conference Call Transcript
    TheStreet | 02/13/15 - 04:24 AM EST
DVA Performance as of Prev. Close
DVA EPS Performance
1-Yr Ago
2-Yrs Ago
3-Yrs Ago
DVA Percentage in these ETFs
DVA News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

DVA DaVita HealthCare Partners Inc

Chart of DVA

Analysts Ratings for DVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

DVA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs